Center for Scientific Review; Notice of Closed Meetings, 66464-66465 [2023-20977]

Download as PDF 66464 Federal Register / Vol. 88, No. 186 / Wednesday, September 27, 2023 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; R13 Conference Grant Review. Date: November 14–15, 2023. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W542, Rockville, Maryland 20850 (Virtual Meeting). Contact Person: Biman Chandra Paria, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W542, Rockville, Maryland 20850, 240–858–3814, pariab@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SBIR Phase IIB Bridge Awards. Date: November 16, 2023. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W238, Rockville, Maryland 20850 (Telephone Conference Call). Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W238, Rockville, Maryland 20850, 240–276–6371, decluej@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Small Business Transition Grant for Early Career Scientists. Date: November 30, 2023. Time: 9:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W238, Rockville, Maryland 20850 (Telephone Conference Call). Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W238, Rockville, Maryland 20850, 240–276–6371, decluej@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, VerDate Sep<11>2014 18:44 Sep 26, 2023 Jkt 259001 Cancer Control, National Institutes of Health, HHS) Dated: September 21, 2023. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–20956 Filed 9–26–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group; Translational Immuno-oncology Study Section. Date: October 19–20, 2023. Time: 8:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814. Contact Person: Maria Elena Cardenas-Corona, Ph.D.. Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20817, 301–867–5309, maria.cardenascorona@nih.gov. Name of Committee: Infectious Diseases and Immunology B Integrated Review Group; Transplantation, Tolerance, and Tumor Immunology Study Section. Date: October 19–20, 2023. Time: 8:30 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD 20852. Contact Person: Carmen Angeles Ufret-Vincenty, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, PO 00000 Frm 00104 Fmt 4703 Sfmt 4703 (301) 594–0912, carmen.ufret-vincenty@ nih.gov. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Molecular and Cellular Neuropharmacology Study Section. Date: October 19–20, 2023. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Vanessa S Boyce, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Rm. 4185, MSC 7850, Bethesda, MD 20892, (301) 402–3726, boycevs@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Collaborative Applications: Clinical Studies of Mental Illness. Date: October 19, 2023. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Allison Kurti, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1007J, Bethesda, MD 20892, (301) 594– 1814, kurtian@csr.nih.gov. Name of Committee: Population Sciences and Epidemiology Integrated Review Group; Neurological, Mental and Behavioral Health Study Section. Date: October 19–20, 2023. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Allison Kurti, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1007J, Bethesda, MD 20892, (301) 594– 1814, kurtian@csr.nih.gov. Name of Committee: Vascular and Hematology Integrated Review Group; Hemostasis, Thrombosis, Blood Cells and Transfusion Study Section. Date: October 19–20, 2023. Time: 9:00 a.m. to 9:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Vivian Tang, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of E:\FR\FM\27SEN1.SGM 27SEN1 ddrumheller on DSK120RN23PROD with NOTICES1 Federal Register / Vol. 88, No. 186 / Wednesday, September 27, 2023 / Notices Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–6208, tangvw@ csr.nih.gov. Name of Committee: Emerging Technologies and Training Neurosciences Integrated Review Group; Bioengineering of Neuroscience, Vision and Low Vision Technologies Study Section, Bioengineering of Neuroscience and Vision Technologies. Date: October 19–20, 2023. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Tina Tze-Tsang Tang, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Suite 3030, Bethesda, MD 20817, (301) 435– 4436, tangt@mail.nih.gov. Name of Committee: Integrative, Functional and Cognitive Neuroscience Integrated Review Group; Learning, Memory and Decision Neuroscience Study Section. Date: October 19–20, 2023. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Roger Janz, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 402–8515, janzr2@ csr.nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Genetic Variation and Evolution Study Section. Date: October 19–20, 2023. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: North Bethesda Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Guoqin Yu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435–1276, guoqin.yu@ nih.gov. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group; Molecular Cancer Diagnosis and Classification Study Section. Date: October 19–20, 2023. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. VerDate Sep<11>2014 18:44 Sep 26, 2023 Jkt 259001 Place: North Bethesda Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6152, MSC 7804 Bethesda, MD 20892, 301–435–1719, ngkl@csr.nih.gov. Name of Committee: Biobehavioral and Behavioral Processes Integrated Review Group; Adult Psychopathology and Disorders of Aging Study Section. Date: October 19–20, 2023. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Benjamin G Shapero, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3182, MSC 7848, Bethesda, MD 20892, (301) 402–4786, shaperobg@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: September 21, 2023. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–20977 Filed 9–26–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [OMB Control Number 1651–0121] Agency Information Collection Activities; Revision of Existing Collection; Trusted Traveler Programs and U.S. APEC Business Travel Card U.S. Customs and Border Protection (CBP), Department of Homeland Security. ACTION: 30-Day Notice and request for comments; revision of an existing collection of information. AGENCY: The Department of Homeland Security, U.S. Customs and Border Protection will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork SUMMARY: PO 00000 Frm 00105 Fmt 4703 Sfmt 4703 66465 Reduction Act of 1995 (PRA). The information collection is published in the Federal Register to obtain comments from the public and affected agencies. DATES: Comments are encouraged and must be submitted (no later than October 27, 2023) to be assured of consideration. ADDRESSES: Written comments and/or suggestions regarding the item(s) contained in this notice should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain . Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: Requests for additional PRA information should be directed to Seth Renkema, Chief, Economic Impact Analysis Branch, U.S. Customs and Border Protection, Office of Trade, Regulations and Rulings, 90 K Street NE, 10th Floor, Washington, DC 20229–1177, Telephone number 202–325–0056 or via email CBP_PRA@cbp.dhs.gov. Please note that the contact information provided here is solely for questions regarding this notice. Individuals seeking information about other CBP programs should contact the CBP National Customer Service Center at 877–227–5511, (TTY) 1–800–877–8339, or CBP website at https://www.cbp.gov/ . SUPPLEMENTARY INFORMATION: CBP invites the general public and other Federal agencies to comment on the proposed and/or continuing information collections pursuant to the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). This proposed information collection was previously published in the Federal Register (87 FR 33178) on June 01, 2022, allowing for a 60-day comment period. This notice allows for an additional 30 days for public comments. This process is conducted in accordance with 5 CFR 1320.8. Written comments and suggestions from the public and affected agencies should address one or more of the following four points: (1) whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) suggestions to enhance the quality, utility, and clarity of the information to be collected; and (4) suggestions to minimize the burden of the collection of E:\FR\FM\27SEN1.SGM 27SEN1

Agencies

[Federal Register Volume 88, Number 186 (Wednesday, September 27, 2023)]
[Notices]
[Pages 66464-66465]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20977]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review Group; Translational Immuno-oncology Study Section.
    Date: October 19-20, 2023.
    Time: 8:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, 
MD 20814.
    Contact Person: Maria Elena Cardenas-Corona, Ph.D.. Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20817, 301-867-5309, 
[email protected].

    Name of Committee: Infectious Diseases and Immunology B Integrated 
Review Group; Transplantation, Tolerance, and Tumor Immunology Study 
Section.
    Date: October 19-20, 2023.
    Time: 8:30 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD 20852.
    Contact Person: Carmen Angeles Ufret-Vincenty, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0912, 
[email protected].

    Name of Committee: Molecular, Cellular and Developmental 
Neuroscience Integrated Review Group; Molecular and Cellular 
Neuropharmacology Study Section.
    Date: October 19-20, 2023.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Vanessa S Boyce, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Rm. 4185, MSC 7850, Bethesda, MD 20892, (301) 402-
3726, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Collaborative Applications: Clinical Studies of Mental Illness.
    Date: October 19, 2023.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Allison Kurti, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 1007J, Bethesda, MD 20892, (301) 594-1814, 
[email protected].

    Name of Committee: Population Sciences and Epidemiology Integrated 
Review Group; Neurological, Mental and Behavioral Health Study Section.
    Date: October 19-20, 2023.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Allison Kurti, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 1007J, Bethesda, MD 20892, (301) 594-1814, 
[email protected].

    Name of Committee: Vascular and Hematology Integrated Review Group; 
Hemostasis, Thrombosis, Blood Cells and Transfusion Study Section.
    Date: October 19-20, 2023.
    Time: 9:00 a.m. to 9:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Vivian Tang, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of

[[Page 66465]]

Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-6208, 
[email protected].

    Name of Committee: Emerging Technologies and Training Neurosciences 
Integrated Review Group; Bioengineering of Neuroscience, Vision and Low 
Vision Technologies Study Section, Bioengineering of Neuroscience and 
Vision Technologies.
    Date: October 19-20, 2023.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Tina Tze-Tsang Tang, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of Health, 
6701 Rockledge Drive, Suite 3030, Bethesda, MD 20817, (301) 435-4436, 
[email protected].

    Name of Committee: Integrative, Functional and Cognitive 
Neuroscience Integrated Review Group; Learning, Memory and Decision 
Neuroscience Study Section.
    Date: October 19-20, 2023.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Roger Janz, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 402-8515, 
[email protected].

    Name of Committee: Genes, Genomes, and Genetics Integrated Review 
Group; Genetic Variation and Evolution Study Section.
    Date: October 19-20, 2023.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: North Bethesda Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Guoqin Yu, Ph.D., Scientific Review Officer, Center 
for Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Bethesda, MD 20892, (301) 435-1276, [email protected].

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review Group; Molecular Cancer Diagnosis and Classification Study 
Section.
    Date: October 19-20, 2023.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: North Bethesda Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of Health, 
6701 Rockledge Drive, Room 6152, MSC 7804 Bethesda, MD 20892, 301-435-
1719, [email protected].

    Name of Committee: Biobehavioral and Behavioral Processes 
Integrated Review Group; Adult Psychopathology and Disorders of Aging 
Study Section.
    Date: October 19-20, 2023.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Benjamin G Shapero, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of Health, 
6701 Rockledge Drive, Room 3182, MSC 7848, Bethesda, MD 20892, (301) 
402-4786, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: September 21, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-20977 Filed 9-26-23; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.